SMTI

Sanara MedTech Inc. (SMTI) ESG Analysis Analysis (2026)

Invetso Score: 6.3/10 — Balanced · Last Updated: 2026-08-01

Environmental

SMTI's R&D intensity of 4.5% of revenue suggests some product-efficiency investment, but peers with heavier clean-technology spending likely show stronger environmental alignment.

The absence of disclosed emissions, energy, or waste metrics limits comparability, leaving SMTI less transparent than peers that report clearer environmental targets and outcomes.

High gross margin can support resource efficiency, yet it does not by itself demonstrate lower environmental impact versus peers in the same industrial cohort.

No post-August 2025 evidence indicates material environmental controversies, so SMTI appears broadly neutral rather than structurally advantaged on environmental risk management.

Social

Low stock-based compensation at 0.46% of revenue suggests restrained dilution, but it is only an indirect proxy for employee alignment versus peers.

The provided data do not disclose workforce safety, turnover, diversity, or training metrics, making SMTI less assessable than peers with fuller social reporting.

If SMTI operates in a regulated or service-intensive setting, limited social disclosure can elevate reputational risk relative to peers with stronger stakeholder transparency.

No recent controversy data were provided, so SMTI appears neither clearly impaired nor clearly leading peers on social execution.

Governance

Debt-to-equity of 6.1x and net debt-to-EBITDA of 3.5x indicate a more leveraged capital structure than many peers, increasing governance sensitivity around capital discipline.

Low stock-based compensation supports some alignment, but the available metrics do not show board independence, audit quality, or shareholder-rights strength versus peers.

The lack of filing-based governance disclosures in the provided data prevents confirmation of stronger controls that would distinguish SMTI from peer companies.

Overall governance positioning appears mixed, with leverage the main relative weakness and no evidence of a severe governance failure.

Overall Score

SMTI's ESG positioning is broadly average versus peers, with limited disclosure and elevated leverage offsetting modest signs of capital discipline.

Score Driver: Elevated Leverage Relative To Peers Is The Most Material Factor Constraining Governance And Overall ESG Positioning.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on Sanara MedTech Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →